These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 18903734)

  • 1. A resolution of mepacrine [2-chloro-5-(sigma-diethylamino-alpha-methylbutyl) amino-7-methoxyacridine].
    BROWN BR; HAMMICK DL
    J Chem Soc; 1948 Jan; ():99. PubMed ID: 18903734
    [No Abstract]   [Full Text] [Related]  

  • 2. A resolution of mepacrine [2-chloro-5-(delta-diethylamino-alpha-methylbutyl) amino-7-methoxyacridine].
    BROWN BR; HAMMICK DL
    J Chem Soc; 1948 Feb; ():99. PubMed ID: 18906361
    [No Abstract]   [Full Text] [Related]  

  • 3. The three-dimensional hydrogen-bonded framework structure in the 1:1 proton-transfer compound of the drug quinacrine with 5-sulfosalicylic acid.
    Smith G; Wermuth UD
    Acta Crystallogr C; 2008 Aug; 64(Pt 8):o428-30. PubMed ID: 18682649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primaquine analogues: derivatives of 4-amino-2-methoxyacridine.
    Scovill JP; Klayman DL; Woods TS; Sweeney TR
    J Med Chem; 1979 Oct; 22(10):1164-7. PubMed ID: 117105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flow cytometric mepacrine fluorescence can be used for the exclusion of platelet dense granule deficiency.
    van Asten I; Blaauwgeers M; Granneman L; Heijnen HFG; Kruip MJHA; Beckers EAM; Coppens M; Eikenboom J; Tamminga RYJ; Pasterkamp G; Huisman A; van Galen KPM; Korporaal SJA; Schutgens REG; Urbanus RT
    J Thromb Haemost; 2020 Mar; 18(3):706-713. PubMed ID: 31815339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mepacrine (quinacrine) inhibition of thrombin-induced platelet responses can be overcome by lysophosphatidic acid.
    McCrea JM; Robinson P; Gerrard JM
    Biochim Biophys Acta; 1985 Oct; 842(2-3):189-94. PubMed ID: 3931692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A flow cytometric assay using mepacrine for study of uptake and release of platelet dense granule contents.
    Wall JE; Buijs-Wilts M; Arnold JT; Wang W; White MM; Jennings LK; Jackson CW
    Br J Haematol; 1995 Feb; 89(2):380-5. PubMed ID: 7873389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mepacrine-induced inhibition of human platelet cyclic-GMP phosphodiesterase.
    Yamakado T; Tanaka F; Hidaka H
    Biochim Biophys Acta; 1984 Sep; 801(1):111-6. PubMed ID: 6147162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of malaria by mepacrine.
    WYNNE-GRIFFITH G
    J R Army Med Corps; 1947 Sep; 89(3):112-21. PubMed ID: 20271469
    [No Abstract]   [Full Text] [Related]  

  • 10. Action of mepacrine on gastric secretion.
    PETCH CP
    Lancet; 1947 Oct; 2(6476):561. PubMed ID: 20344807
    [No Abstract]   [Full Text] [Related]  

  • 11. Temporary insanity due to mepacrine.
    CHATTERJEE K; LILLY KS
    Indian Med J; 1947 Aug; 41(8):153. PubMed ID: 20344787
    [No Abstract]   [Full Text] [Related]  

  • 12. On the chemical basis of chromosome banding patterns.
    Tsou KC; Giles B; Kohn G
    Stain Technol; 1975 Sep; 50(5):293-5. PubMed ID: 54951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Access and use of quinacrine (mepacrine) in the treatment of resistant giardiasis.
    Delaye C; Suarez F; Aguilar C; Guerin C; Batista R; Chasport C; Paugam A; Zerbit J
    Infect Dis Now; 2021 Nov; 51(8):682-684. PubMed ID: 33774205
    [No Abstract]   [Full Text] [Related]  

  • 14. Determination of quinacrine (mepacrine) in plasma by high-performance liquid chromatography with fluorimetric detection.
    Björkman S; Elisson LO
    J Chromatogr; 1987 Sep; 420(2):341-8. PubMed ID: 3693505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resolution of mepacrine.
    BROWN BR; HAMMICK DL
    Nature; 1947 May; 159(4044):612. PubMed ID: 20239718
    [No Abstract]   [Full Text] [Related]  

  • 16. Mepacrine blockade of arachidonate-induced washed platelet aggregation: relationship to mepacrine inhibition of platelet cyclooxygenase.
    Raz A
    Thromb Haemost; 1983 Dec; 50(4):784-6. PubMed ID: 6420923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effect of mepacrine on hypoxia-reoxygenation-induced acute lung injury in rats.
    Shen CY; Wang D; Chang ML; Hsu K
    J Appl Physiol (1985); 1995 Jan; 78(1):225-31. PubMed ID: 7713816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The excretion of mepacrine in the faeces.
    MAEGRAITH BG; BROWN GM
    Ann Trop Med Parasitol; 1946 Dec; 40(3-4):372-9. PubMed ID: 20289239
    [No Abstract]   [Full Text] [Related]  

  • 19. Mepacrine-induced inhibition of the inward current mediated by 5-HT3 receptors in rat nodose ganglion neurones.
    Fan P
    Br J Pharmacol; 1994 Jul; 112(3):745-8. PubMed ID: 7522858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mepacrine protects the isolated rat heart during hypoxia and reoxygenation--but not by inhibition of phospholipase A2.
    Bugge E; Gamst TM; Hegstad AC; Andreasen T; Ytrehus K
    Basic Res Cardiol; 1997 Feb; 92(1):17-24. PubMed ID: 9062648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.